The analysis of mortality outcomes presented a worrying trend, with vancomycin treatment having more than alternative therapies and a relationship with mortality rates (OR 1.25; 95% CI (1.00, 1.56)).
← all excerpts
Efficacy and Safety of Vancomycin, Linezolid, and Ceftaroline in the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA): A Systematic Review and Meta-Analysis.
1
—
—